Cargando…

Interferon-lambda: New role in intestinal symptoms of COVID-19

The tremendous public health and economic impact of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a huge challenge globally. There is increasing evidence that SARS-CoV-2 induces intestinal infections. Type III interferon (IFN-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yi-Yang, Wang, Liu-Can, Yang, Feng, Yu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122791/ https://www.ncbi.nlm.nih.gov/pubmed/37155525 http://dx.doi.org/10.3748/wjg.v29.i13.1942

Ejemplares similares

Frontiers of COVID-19-related myocarditis as assessed by cardiovascular magnetic resonance
por: Luo, Yi, et al.
Publicado: (2022)

Role of the extracellular matrix in COVID-19
por: Huang, Jia-Jia, et al.
Publicado: (2023)

COVID-19 and liver dysfunction in children: Current views and new hypotheses
por: Yun, Yang-Fang, et al.
Publicado: (2023)

Role of gut microbiota on intestinal barrier function in acute pancreatitis
por: Li, Xue-Yang, et al.
Publicado: (2020)

Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19
por: Jin, Byungchang, et al.
Publicado: (2021)

Role of γδT cells in liver diseases and its relationship with intestinal microbiota
por: Zhou, Qi-Hui, et al.
Publicado: (2020)

New progress in understanding roles of nitric oxide during hepatic ischemia-reperfusion injury
por: Zhang, Yi-Ping, et al.
Publicado: (2022)

Prognostic role of intestinal ultrasound in Crohn’s disease
por: Manzotti, Cristina, et al.
Publicado: (2023)

Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
por: Zhang, Yang, et al.
Publicado: (2021)

Legacy of neuropsychiatric symptoms associated with past COVID-19 infection: A cause of concern
por: De Berardis, Domenico, et al.
Publicado: (2022)

Early Treatment with Pegylated Interferon Lambda for Covid-19
por: Reis, Gilmar, et al.
Publicado: (2023)

Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections
por: Lee, Sanghyun, et al.
Publicado: (2017)

Multiple roles for cholinergic signaling in pancreatic diseases
por: Yang, Jun-Min, et al.
Publicado: (2022)

Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
por: Gangadharan, Charitha, et al.
Publicado: (2021)

Role of natural products and intestinal flora on type 2 diabetes mellitus treatment
por: Aydin, Ozlem Celik, et al.
Publicado: (2023)

New role for ceramide in hypoxia and insulin resistance
por: Xia, Qing-Song, et al.
Publicado: (2020)

Lambda Interferons: New Cytokines with Old Functions
por: Hamming, Ole J., et al.
Publicado: (2010)

Role of proning and positive end-expiratory pressure in COVID-19
por: Gandhi, Kejal D, et al.
Publicado: (2021)

Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases
por: Zhang, Mei, et al.
Publicado: (2016)

New progress in roles of nitric oxide during hepatic ischemia reperfusion injury
por: Zhang, Ya-Qi, et al.
Publicado: (2017)

Intestine in the lung
por: Slack, Jonathan MW
Publicado: (2004)

Interferon-Stimulated Gene 15 in the Control of Cellular Responses to Genotoxic Stress
por: Jeon, Young Joo, et al.
Publicado: (2017)

COVID‐19: lambda interferon against viral load and hyperinflammation
por: Andreakos, Evangelos, et al.
Publicado: (2020)

COVID-19 and emerging viral infections: The case for interferon lambda
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2020)

Treatment strategies for gastric cancer during the COVID-19 pandemic
por: Kang, Wen-Zhe, et al.
Publicado: (2020)

Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways
por: Manes, Nathan P., et al.
Publicado: (2021)

Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
por: Zhang, Chun-Ye, et al.
Publicado: (2022)

Medicinal nicotine in COVID-19 acute respiratory distress syndrome, the new corticosteroid
por: Ahmad, Farrukh
Publicado: (2022)

Standardization of critical care management of non-critically ill patients with COVID-19
por: Wang, Chang-Song, et al.
Publicado: (2021)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis
por: D'Andrea, Antonello, et al.
Publicado: (2020)

Potential role of the microbiome in liver injury during COVID-19: Further research is needed
por: Tovani-Palone, Marcos Roberto, et al.
Publicado: (2023)

May 2022 acute hepatitis outbreak, is there a role for COVID-19 and other viruses?
por: Elbeltagi, Reem, et al.
Publicado: (2023)

Holistic care model of time-sharing management for severe and critical COVID-19 patients
por: Yang, Bo, et al.
Publicado: (2020)

The genomics of probiotic intestinal microorganisms
por: Salminen, Seppo, et al.
Publicado: (2005)

Healthcare practice strategies for integrating personalized medicine: Management of COVID-19
por: Liu, Wen-Yi, et al.
Publicado: (2021)

Etiology and management of liver injury in patients with COVID-19
por: Yang, Rui-Xu, et al.
Publicado: (2020)

Multifunctional biomimetic spinal cord: New approach to repair spinal cord injuries
por: Liu, Yang, et al.
Publicado: (2017)

COVID-19 and liver dysfunction: What nutritionists need to know
por: Wang, Ming-Ke, et al.
Publicado: (2022)

Interferon Lambda: A New Sword in Cancer Immunotherapy
por: Lasfar, Ahmed, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ef9a0cus52qugtekchvsio33ns